Analysis of related factors for systemic lupus erythematosus flare after SARS ‐Cov‐2 infection: A retrospective cohort study
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.15407 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Qian Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: 2023 COVID-19 Emergency Project of Shanxi Bethune Hospital, 2023 COVID-19 Emergency Project of Shanxi Health Commission, Shanxi Graduate Education Innovation Project (No. 2023SJ137).
Abstract (Originalsprache)
Objective
Since COVID‐19 infections are more common in systemic lupus erythematosus (SLE) patients, most recent research has focused on the outcome of COVID‐19, with fewer studies on disease activity in SLE. This research aims to evaluate flares in SLE with COVID‐19 infection while investigating predictive factors.
Methods
A questionnaire survey was conducted to collect information on patients with previously diagnosed SLE from multi‐center. SLE patients infected with COVID‐19 after December 7, 2022, were selected. Detailed information covering demographic characteristics, SLE and COVID‐19 clinical features, disease activity, and medication was collected through an electronic questionnaire. A multivariate logistic regression model was constructed to evaluate the predictive factors for SLE disease onset after COVID‐19 infection.
Results
A total of 240 patients were finally included in our analysis. Thirty (12.5%) of those enrolled reported an SLE flare. Multivariate analysis with logistic models confirmed that SLE in the active stage (OR 2.617, 95% CI 1.008–6.514, p = .041) and COVID‐19 duration (OR 4.140, 95% CI 1.412–11.694, p = .008) were predictors for flare in SLE patients with Covid‐19 infection. In contrast, immunosuppressants were associated with a low incidence of flare of SLE (OR 0.138, 95% CI 0.042–0.46, p = .005).
Conclusions
The active phase of SLE and the progression of COVID‐19 were the main risk factors for disease exacerbation in SLE patients, while the use of immunosuppressive medications was associated with a lower risk of flare‐ups. These findings provide valuable insights for managing SLE patients during the COVID‐19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
- Department of Scientific Research, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China.
ORCID-Profile: Qian Li, Ya-Zhen Su, Yang Liu
Förderung
- 2023 COVID-19 Emergency Project of Shanxi Bethune Hospital
- 2023 COVID-19 Emergency Project of Shanxi Health Commission
- Shanxi Graduate Education Innovation Project (No. 2023SJ137)
- Free Exploration Youth Project from the Science and Technology Department of Shanxi Province (No. 202303021222314)
- Shanxi Province Clinical Theranostics Technology Innovation Center for Immunologic and Rheumatic Diseases (No. CXZX-202305)
Zitieren
APA
Li, Q., Zhao, J. K., Zhang, J. Y., Li, R., Zhao, L., Su, Y. Z., Liu, Y., Xu, K., & Zhang, L. Y. (2025). Analysis of related factors for systemic lupus erythematosus flare after SARS ‐Cov‐2 infection: A retrospective cohort study. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15407
Vancouver
Li Q, Zhao JK, Zhang JY, Li R, Zhao L, Su YZ, et al. Analysis of related factors for systemic lupus erythematosus flare after SARS ‐Cov‐2 infection: A retrospective cohort study. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.15407
BibTeX
@article{Li2025,
author = {Li, Qian and Zhao, Jun-Kang and Zhang, Jun-Yan and Li, Rong and Zhao, Li and Su, Ya-Zhen and Liu, Yang and Xu, Ke and Zhang, Li-Yun},
title = {Analysis of related factors for systemic lupus erythematosus flare after SARS ‐Cov‐2 infection: A retrospective cohort study},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.15407}
}
EUVIMED